Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with Paclitaxel for Advanced Gastric Cancer
NCT03604614Phase 2Unknown
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of paclitaxel oral solution in gastric cancer (GC) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Progression-Free Survival at 7 months. Status: unknown.
02
Drugs
paclitaxel oral solution
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03604614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604614.